ctrl K

AI Score

Unlock

Zentalis Pharmaceuticals ... (ZNTL)

AI Score

Unlock

1.92

-0.15 (-7.25%)

At close: Mar 03, 2025, 3:59 PM

1.92

0.00%

After-hours: Mar 03, 2025, 04:00 PM EST

Zentalis Pharmaceuticals Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	14K
Cost of Revenue	1.39M	1.43M	544K	160K	111K	n/a
Gross Profit	-1.39M	-1.43M	-544K	-160K	-111K	14K
Operating Income	-248.99M	-227.29M	-216.54M	-118.79M	-46.84M	-23.78M
Interest Income	n/a	2.26K	1.31K	1.24K	498K	355K
Pretax Income	-276.89M	-221.3M	-164.56M	-118.1M	-46.36M	-23.43M
Net Income	-292.19M	-220.83M	-164.26M	-118.55M	-46.38M	-21.07M
Selling & General & Admin	59.4M	54.55M	40.94M	33.89M	8.46M	4.88M
Research & Development	189.59M	172.73M	175.6M	84.9M	38.39M	18.92M
Other Expenses	n/a	n/a	n/a	n/a	-16K	n/a
Operating Expenses	252.55M	227.29M	216.54M	118.79M	46.84M	23.8M
Interest Expense	n/a	2.58M	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	253.94M	227.29M	216.54M	118.79M	46.84M	23.8M
Income Tax	-601K	-469K	-297K	444K	15K	4K
Shares Outstanding (Basic)	65.41M	52.86M	42.69M	41.04M	35.88M	18.06M
Shares Outstanding (Diluted)	65.41M	52.86M	42.69M	41.04M	35.88M	18.06M
EPS (Basic)	-4.47	-4.18	-3.85	-2.89	-1.29	-1.17
EPS (Diluted)	-4.47	-4.18	-3.85	-2.89	-1.29	-1.17
EBITDA	-275.5M	-219.87M	-164.01M	-117.94M	-46.73M	-23.73M
Depreciation & Amortization	1.39M	1.43M	544K	160K	111K	51.49K